Local Anaesthetics Toxicity and Intralipid®

NCT01602250 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Toxicity
Adverse Effects

Interventions

DRUG: placebo
DRUG: Intralipid®

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]